Literature DB >> 3143586

Comparative in vitro activity of the new oxacephem antibiotic, flomoxef (6315-S).

G Ruckdeschel1, W Eder.   

Abstract

The in vitro activity of flomoxef (6315-S) was determined and compared to that of different cephalosporins against 787 clinical isolates of staphylococci, Enterobacteriaceae and anaerobes. Flomoxef is similar in activity to latamoxef and cefotaxime against Enterobacteriaceae, slightly more active than cephalothin and cefamandole against oxacillin-sensitive strains of Staphylococcus aureus and minimally less active than cefamandole against oxacillin-resistant strains. Flomoxef showed similar or better activity than latamoxef and cefoxitin against most of the anaerobic species of medical importance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3143586     DOI: 10.1007/bf01964256

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  2 in total

1.  Production of low-affinity penicillin-binding protein by low- and high-resistance groups of methicillin-resistant Staphylococcus aureus.

Authors:  K Murakami; K Nomura; M Doi; T Yoshida
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

2.  In vitro activity and beta-lactamase stability of a new difluoro oxacephem, 6315-S.

Authors:  H C Neu; N X Chin
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

  2 in total
  1 in total

Review 1.  Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.

Authors:  Christopher A Darlow; Renata M A da Costa; Sally Ellis; François Franceschi; Mike Sharland; Laura Piddock; Shampa Das; William Hope
Journal:  Paediatr Drugs       Date:  2021-08-26       Impact factor: 3.022

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.